Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 212 institutions that hold shares in the stock, with a total of 103 Million shares, which have been reported (via 13F filing form) to have a value of $1.16 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
315,602
shares
|
$3.72 Million
0.01% of portfolio
|
Q4 2024
Added 0.91%
|
|
|
Frontier Capital Management CO LLC
|
Feb 14, 2025 Q4 2024 |
298,052
shares
|
$3.52 Million
0.07% of portfolio
|
Q4 2024
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
267,377
shares
|
$3.16 Million
0.01% of portfolio
|
Q4 2024
Added 1054.18%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
266,404
shares
|
$3.14 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.62%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
249,803
shares
|
$2.95 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.19%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
236,262
shares
|
$2.79 Million
1.15% of portfolio
|
Q4 2024
Added 318.13%
|
|
|
Ratan Capital Management LP
Miami Beach, FL |
Feb 13, 2025 Q4 2024 |
230,900
shares
|
$2.72 Million
0.98% of portfolio
|
Q2 2024
Added 696.21%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
229,121
shares
|
$2.7 Million
0.03% of portfolio
|
Q4 2024
Reduced 46.47%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
219,635
shares
|
$2.59 Million
0.0% of portfolio
|
Q4 2024
Added 3.16%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
192,239
shares
|
$2.27 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.27%
|
|
|
Axa S.A.
Paris, I0 |
Feb 14, 2025 Q4 2024 |
188,651
shares
|
$2.23 Million
0.01% of portfolio
|
Q2 2024
Added 11.4%
|
|
|
Crestline Management, LP
Fort Worth, TX |
Feb 13, 2025 Q4 2024 |
184,818
shares
|
$2.18 Million
0.15% of portfolio
|
Q4 2024
Added 57.05%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
169,306
shares
|
$2 Million
0.01% of portfolio
|
Q4 2024
Reduced 30.93%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
167,482
shares
|
$1.98 Million
0.01% of portfolio
|
Q4 2024
Added 1.53%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
153,218
shares
|
$1.81 Million
0.0% of portfolio
|
Q4 2024
Reduced 16.82%
|
|
|
Neuberger Berman Group LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
152,306
shares
|
$1.8 Million
0.0% of portfolio
|
Q4 2024
Added 11.12%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
150,000
shares
|
$1.77 Million
0.32% of portfolio
|
Q4 2024
New holding
|
|
|
Schroder Investment Management Group
London, X0 |
Feb 12, 2025 Q4 2024 |
147,002
shares
|
$1.73 Million
0.0% of portfolio
|
Q4 2024
Added 63.26%
|
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
145,510
shares
|
$1.72 Million
0.0% of portfolio
|
Q4 2024
Reduced 43.14%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
143,363
shares
|
$1.69 Million
0.0% of portfolio
|
Q4 2024
Added 6.72%
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
142,917
shares
|
$1.69 Million
0.0% of portfolio
|
Q4 2024
Added 121.79%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
137,751
shares
|
$1.63 Million
0.42% of portfolio
|
Q3 2023
Reduced 54.2%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
133,772
shares
|
$1.58 Million
0.0% of portfolio
|
Q4 2024
Added 83.15%
|
|
|
Springhill Fund Asset Management (Hk) CO LTD
Hong Kong, K3 |
Feb 13, 2025 Q4 2024 |
131,200
shares
|
$1.55 Million
5.02% of portfolio
|
Q4 2024
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
128,290
shares
|
$1.51 Million
0.0% of portfolio
|
Q4 2024
Added 22.75%
|